Publications in collaboration with researchers from Universidad Complutense de Madrid (20)

2023

  1. A Review: Integrative Perspectives on the Features and Clinical Management of Psychotic Episodes in Pregnancy

    Journal of Clinical Medicine, Vol. 12, Núm. 2

  2. Evidence of Increased Oxidative Stress in the Placental Tissue of Women Who Suffered an Episode of Psychosis during Pregnancy

    Antioxidants, Vol. 12, Núm. 1

  3. Microbiota–gut–brain axis mechanisms in the complex network of bipolar disorders: potential clinical implications and translational opportunities

    Molecular Psychiatry, Vol. 28, Núm. 7, pp. 2645-2673

  4. The Placentas of Women Who Suffer an Episode of Psychosis during Pregnancy Have Increased Lipid Peroxidation with Evidence of Ferroptosis

    Biomolecules, Vol. 13, Núm. 1

  5. Women with psychotic episodes during pregnancy show increased markers of placental damage with Tenney-Parker changes

    Histology and Histopathology, Vol. 38, Núm. 10, pp. 1109-1118

2022

  1. An Updated View of the Importance of Vesicular Trafficking and Transport and Their Role in Immune-Mediated Diseases: Potential Therapeutic Interventions

    Membranes, Vol. 12, Núm. 6

  2. Biological Role of Nutrients, Food and Dietary Patterns in the Prevention and Clinical Management of Major Depressive Disorder

    Nutrients, Vol. 14, Núm. 15

  3. Chronic Venous Disease during Pregnancy Causes a Systematic Increase in Maternal and Fetal Proinflammatory Markers

    International journal of molecular sciences, Vol. 23, Núm. 16

  4. Differential malondialdehyde (MDA) detection in plasma samples of patients with major depressive disorder (MDD): A potential biomarker

    Journal of International Medical Research, Vol. 50, Núm. 5

  5. Gut Microbiota Metabolites in Major Depressive Disorder—Deep Insights into Their Pathophysiological Role and Potential Translational Applications

    Metabolites, Vol. 12, Núm. 1

  6. Immune-Mediated Diseases from the Point of View of Psychoneuroimmunoendocrinology

    Biology, Vol. 11, Núm. 7

  7. Nutrition, Epigenetics, and Major Depressive Disorder: Understanding the Connection

    Frontiers in Nutrition, Vol. 9

  8. Understanding the basis of major depressive disorder in oncological patients: Biological links, clinical management, challenges, and lifestyle medicine

    Frontiers in Oncology, Vol. 12

2021

  1. A predictive model and risk factors for case fatality of covid-19

    Journal of Personalized Medicine, Vol. 11, Núm. 1, pp. 1-18

  2. Abnormal proinflammatory and stressor environmental with increased the regulatory cellular igf-1/papp-a/ stc and wnt-1/β-catenin canonical pathway in placenta of women with chronic venous disease during pregnancy

    International Journal of Medical Sciences, Vol. 18, Núm. 13, pp. 2814-2827

  3. An updated review of sars-cov-2 vaccines and the importance of effective vaccination programs in pandemic times

    Vaccines, Vol. 9, Núm. 5

  4. Expansion of CD4 T lymphocytes expressing interleukin 17 and tumor necrosis factor in patients with major depressive disorder

    Journal of Personalized Medicine, Vol. 11, Núm. 3

  5. Exploring the role of nutraceuticals in major depressive disorder (MDD): Rationale, state of the art and future prospects

    Pharmaceuticals, Vol. 14, Núm. 8

  6. Micrornas as critical biomarkers of major depressive disorder: A comprehensive perspective

    Biomedicines, Vol. 9, Núm. 11

2020

  1. Blunted Expansion of Regulatory T Lymphocytes Is Associated With Increased Bacterial Translocation in Patients With Major Depressive Disorder

    Frontiers in Psychiatry, Vol. 11